Nunes Anne - Insider Non-Derivative Transactions at Anika Therapeutics, Inc. (ANIK) - (SEC)

Updated on January 3, 2026.

According to recent SEC insider information filed on Mar 17, 2025, Nunes Anne's relationship to Anika Therapeutics, Inc. (ANIK) is Officer (SVP, Chief Operations Officer), and currently has 21,722 shares of Common Stock.

The chart below shows the number of shares owned, and the table shows the recent insider transactions.

You can see similar information for other ANIK insiders.

Related Topics: SEC Topic List.
Data Source: SEC.
Nunes Anne - Insider Non-Derivative Transactions of ANIK Common Stock
Nunes Anne - Insider Non-Derivative Transactions at ANIK
Items per page:
0 of 0
Date Transaction No. of Shares Price Per Share Shares Owned After Transactions
Mar 18, 2025 F -- (Common Stock) 1068 15.91 20654
Mar 18, 2025 M -- (Common Stock) 3637 0 21722
Mar 12, 2025 F -- (Common Stock) 752 16.79 18085
Mar 12, 2025 M -- (Common Stock) 2561 0 18837
Mar 11, 2025 F -- (Common Stock) 959 16.62 16276
Mar 11, 2025 M -- (Common Stock) 3296 0 17235
Oct 2, 2024 F -- (Common Stock) 732 24.27 13479
Oct 2, 2024 M -- (Common Stock) 2491 0 14211
Mar 12, 2024 F -- (Common Stock) 968 25.42 9277
Mar 12, 2024 M -- (Common Stock) 3295 0 10245
Mar 12, 2024 F -- (Common Stock) 752 25.79 11086
Mar 12, 2024 M -- (Common Stock) 2561 0 11838
Oct 2, 2023 F -- (Common Stock) 732 18.63 5052
Oct 2, 2023 M -- (Common Stock) 2491 0 5784